|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
- 900% revenue growth year-over-year, plus a new partnership with big potential, and Solbright Group ...
WKN: A1C4WM) announced today that it intends to distribute units consisting of shares and warrants of its subsidiary, Australis Capital Inc. ("Australis"), to shareholders of the Company by way of a return of capital. The spin-out of Australis will happen in the form of a distribution of units (the "Units") in Australis Capital to resident holders of Aurora shares (the "Distribution").
Exposure to Unique Canadian Craft Cultivator and Retail Operator TSX: ACB EDMONTON , June 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) ...
NEW YORK, June 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy ...
WKN: A1C4WM) announced today that it intends to complete a $7 million investment in Choom Holdings Inc. ("Choom") (CSE:CHOO) (OTCQB:CHOOF - News), whereby Aurora will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share (the "Transaction"), representing an 8% ownership interest. Choom currently operates two late stage applicants under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). Choom has agreements in place to acquire two additional late-stage applicant craft growers in BC and Saskatchewan, including a facility in Sooke, British Columbia, anticipated to receive its cultivation license from Health Canada in the third quarter of 2018.
Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115 million. Anandia provides research and development services as well as analytical testing for clients licensed under Canada's medical cannabis rules. Aurora CEO Terry Booth says the deal expands his company's capabilities and will help accelerate product development.
Binding term sheet signed, transaction valued at approximately $115 million Unites Anandia, a globally-recognized leader in cannabis science, with Aurora, one of Canada's largest and most innovative Licensed ...
WKN: A1C4WM) and Anandia Laboratories Inc. ("Anandia") announced today that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately $115 million on a fully diluted basis (the "Transaction"). Led by CEO and co-founder Jonathan Page, PhD, one of the industry's most widely recognized cannabis experts, Anandia is considered the industry leader in science, genetics, and independent cannabis product testing.
Aurora Cannabis Inc’s (TSX:ACB): Aurora Cannabis Inc., together with its subsidiaries, produces and distributes medical marijuana products in Canada. With the latest financial year loss of -CA$12.97M and a trailing-twelveRead More...
WKN: A1C4WM) today announced that it has signed a cannabis flower and trim supply agreement (the "Agreement") with Ascent Industries Corp's ("Ascent") wholly-owned subsidiary, Agrima Botanicals Corp. ("Agrima"), a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). Under the terms of the Agreement, Agrima will supply Aurora with up to 20,000 kg of dried cannabis flower and up to 6,000 kg of cannabis trim per year from its Canadian cultivation facilities.
Don't worry that most marijuana stocks fell after the big Canadian Senate vote on Thursday. These three stocks should be winners over the long run.
Aurora Cannabis Inc. (TSX:ACB) and Jamieson Wellness Inc. (TSX:JWEL) are well positioned to generate growth due to the expansion of a key market.
TSX: ACB EDMONTON , June 7, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) comments on today's Canadian Senate's ...
WKN: A1C4WM) and Capcium Inc. ("Capcium") announced today that the companies have signed a strategic agreement to produce high quality cannabis-based softgels for patients. Additionally, Aurora has acquired a 19.99% ownership interest in Capcium by way of a non-brokered private placement for consideration of $10 million. Capcium, a privately-owned Montreal-based global leader in softgel manufacturing, has emerged as one of the leading manufacturers in the cannabis industry. Capcium, through its pharmaceutical and encapsulation experience, has developed expertise that is ready to be applied to the cannabis industry and deliver high-volume production capacity.
NEW YORK, NY / ACCESSWIRE / June 6, 2018 / Major indexes closed mostly higher Tuesday, lifted by a rally from the technology sector. The Dow Jones Industrial Average decreased 0.06 percent to close at ...
Will Canadian pot stocks soar after the Senate vote? Maybe -- but maybe not.
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual event through VirtualInvestorConferences.com EDMONTON, Alberta , June 5, 2018 /CNW/ -- Aurora ...